Lightyear Capital announced that it has completed a strategic investment in CuraLinc Healthcare in a deal guided by Davis Polk & Wardwell and Locke Lord. Financial terms were not disclosed. New York-based Lightyear Capital was advised by Davis Polk. CuraLinc Healthcare, which is based in Chicago, was represented by a Locke Lord team.
Health Care
August 19, 2024, 11:23 AM